LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Ester doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

11&bgr;-fluoro 15&bgr;-hydroxy PGF2&agr; analogs as FP...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

11-deoxy-16-fluoro-PGF2&agr; analogs as FP receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

11-haloprostane derivatives, processes for their preparation and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

11-haloprostane derivatives, processes for their preparation and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

13,14-dihydroprostaglandin C-type derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

13-Aza prostaglandins for the treatment of glaucoma and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

13-Oxa prostaglandins for the treatment of glaucoma and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

13-Thia prostaglandins for use in glaucoma therapy

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

14-aza prostaglandins for the treatment of glaucoma and ocular h

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

15,16-seco-19-nor progestins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

15,16-seco-19-nor progestins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

15,16-seco-19-nor progestins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

15-deoxyspergualin analogs, their method of preparation and thei

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

15-fluoro prostaglandins as ocular hypotensives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

15-fluoro prostaglandins as ocular hypotensives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

16-Methoxy-16-methyl prostaglandin E.sub.1 derivatives, a proces

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

16-methyl-11,16-dihydroxy-9-oxoprost-2,13-dien-1-oic acid and de

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

17 a .beta.-hydroxy-7 .alpha.-methyl-d-homo-19-norandrost-4,16-d

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

2, 4-disulfonyl phenyl butyl nitrone, its salts, and their use a